JDHIY:OTC-JD Health International Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 5.1

Change

0.00 (0.00)%

Market Cap

USD 16.82B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-30 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
ALBHF Alibaba Health Information Tec..

N/A

USD 10.86B
JDHIF JD Health International Inc

N/A

USD 10.33B
CLCGY Clicks Group Ltd

N/A

USD 5.14B
RADLY Raia Drogasil SA ADR

-0.33 (-11.70%)

USD 4.65B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.98B
SAEYY Shop Apotheke Europe N.V

-0.41 (-2.97%)

USD 2.96B
NOTR Nowtransit Inc

N/A

USD 0.57B
ZRSEF Zur Rose Group AG

N/A

USD 0.30B
BLMH Blum Holdings Inc

+0.08 (+11.54%)

USD 0.01B
RLLVF Relevium Technologies Inc

N/A

USD 5.28M

ETFs Containing JDHIY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 33.86% 88% B+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.86% 88% B+ 78% C+
Trailing 12 Months  
Capital Gain 41.27% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.27% 83% B 80% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -14.65% 36% F 21% F
Dividend Return -14.65% 36% F 20% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 24.72% 84% B 78% C+
Risk Adjusted Return -59.23% 28% F 13% F
Market Capitalization 16.82B 100% F 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.